Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMVAMUNE Liquid-frozen vs Freeze-dried in Healthy Subjects
NCT01668537Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Mar 2013
- Primary completion
- Jan 2014
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of JYNNEOS in smallpox, sponsored by Bavarian Nordic. Primary endpoint: Enzyme-Linked Immunosorbent Assay Geometric Mean Titer at 6 weeks. Started Mar 2013; status: completed.
02
Drugs
JYNNEOS
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT01668537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668537.